In an orthotopic xenograft model of hepatocellular carcinoma (HCC), SIRT1 knockdown resulted in 50% fewer animals developing tumours, and small molecule inhibitor cambinol treatment resulted in an overall lower tumour burden, suggesting that SIRT1 expression positively affects the growth of HCC [10]. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.